Literature DB >> 10393187

Silencing at Drosophila telomeres: nuclear organization and chromatin structure play critical roles.

D E Cryderman1, E J Morris, H Biessmann, S C Elgin, L L Wallrath.   

Abstract

Transgenes inserted into the telomeric regions of Drosophila melanogaster chromosomes exhibit position effect variegation (PEV), a mosaic silencing characteristic of euchromatic genes brought into juxtaposition with heterochromatin. Telomeric transgenes on the second and third chromosomes are flanked by telomeric associated sequences (TAS), while fourth chromosome telomeric transgenes are most often associated with repetitious transposable elements. Telomeric PEV on the second and third chromosomes is suppressed by mutations in Su(z)2, but not by mutations in Su(var)2-5 (encoding HP1), while the converse is true for telomeric PEV on the fourth chromosome. This genetic distinction allowed for a spatial and molecular analysis of telomeric PEV. Reciprocal translocations between the fourth chromosome telomeric region containing a transgene and a second chromosome telomeric region result in a change in nuclear location of the transgene. While the variegating phenotype of the white transgene is suppressed, sensitivity to a mutation in HP1 is retained. Corresponding changes in the chromatin structure and inducible activity of an associated hsp26 transgene are observed. The data indicate that both nuclear organization and local chromatin structure play a role in this telomeric PEV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393187      PMCID: PMC1171449          DOI: 10.1093/emboj/18.13.3724

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

1.  P-Element repression in Drosophila melanogaster by a naturally occurring defective telomeric P copy.

Authors:  L Marin; M Lehmann; D Nouaud; H Izaabel; D Anxolabéhère; S Ronsseray
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

2.  Terminal retrotransposons activate a subtelomeric white transgene at the 2L telomere in Drosophila.

Authors:  M D Golubovsky; A Y Konev; M F Walter; H Biessmann; J M Mason
Journal:  Genetics       Date:  2001-07       Impact factor: 4.562

3.  Modifiers of terminal deficiency-associated position effect variegation in Drosophila.

Authors:  Kathryn M Donaldson; Amy Lui; Gary H Karpen
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

4.  The promoter of the heterochromatic Drosophila telomeric retrotransposon, HeT-A, is active when moved into euchromatic locations.

Authors:  Janet A George; Mary-Lou Pardue
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

5.  mediator of paramutation1 is required for establishment and maintenance of paramutation at multiple maize loci.

Authors:  J E Dorweiler; C C Carey; K M Kubo; J B Hollick; J L Kermicle; V L Chandler
Journal:  Plant Cell       Date:  2000-11       Impact factor: 11.277

6.  Telomeric associated sequences of Drosophila recruit polycomb-group proteins in vivo and can induce pairing-sensitive repression.

Authors:  Antoine Boivin; Christelle Gally; Sophie Netter; Dominique Anxolabéhère; Stéphane Ronsseray
Journal:  Genetics       Date:  2003-05       Impact factor: 4.562

7.  A novel genetic tool for clonal analysis of fourth chromosome mutations.

Authors:  Rui Sousa-Neves; Joseph M Schinaman
Journal:  Fly (Austin)       Date:  2012-01-01       Impact factor: 2.160

8.  Lamin C and chromatin organization in Drosophila.

Authors:  B V Gurudatta; L S Shashidhara; Veena K Parnaik
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

Review 9.  A lot about a little dot - lessons learned from Drosophila melanogaster chromosome 4.

Authors:  Nicole C Riddle; Christopher D Shaffer; Sarah C R Elgin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

10.  A deficiency screen for dominant suppressors of telomeric silencing in Drosophila.

Authors:  James M Mason; Joshua Ransom; Alexander Y Konev
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.